COVID-19

News

Clear COVID health information essential for a return to healthcare as normal

Pharma poised to cash in on 'long COVID' symptoms

While there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue to affect patients for some time.

Views & Analysis

Meeting public expectations of diagnostics is the next big t...

Ivor Campbell looks at the way the UK medtech sector has responded to COVID-19 and the implications of more advanced diagnostics for prescribing and general practice.

News

MPs slam £37bn NHS Test and Trace as UK endures third lockdo...

There is no clear evidence that the UK’s £37 billion NHS Test and Trace programme (NHST&T) has an impact on the pandemic, according to a withering report from an influential committee o

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J manufacturing delays hit US vaccine rollout

The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available.

News

Pfizer/BioNTech COVID jab works against Brazil variant; lab ...

A laboratory study suggests Pfizer and BioNTech’s COVID-19 vaccine Comirnaty could be effective against a Brazilian variant of the SARS-CoV-2 virus – known as P.1 – that is worrying health

News

UK data hub to apply AI to health records for COVID-19 and r...

Health Data Research UK’s respiratory hub BREATHE is set to use artificial intelligence (AI) to unlock real-world insights from electronic health records (EHRs) as part of a new partnership

Pharma poised to cash in on 'long COVID' symptoms

Meeting public expectations of diagnostics is the next big t...

MPs slam £37bn NHS Test and Trace as UK endures third lockdo...

J&J manufacturing delays hit US vaccine rollout

Pfizer/BioNTech COVID jab works against Brazil variant; lab ...

UK data hub to apply AI to health records for COVID-19 and r...

Obesity-focused biotech Kailera joins IPO queue in US

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks